Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PTCT PTC Therapeutics > Company Profile
PTCT PTC Therapeutics
41.550
+0.060+0.14%
Symbol
PTCT
Company Name
PTC Therapeutics
Listing Date
06/20/2013
Establishment Date
1998
CEO
Dr. Stuart W. Peltz, PhD
Market
NASDAQ
Employees
1177
Securities Type
DR
Fiscal Year Ends
12-31
Address
100 Corporate Court
City
South Plainfield
Province
New Jersey
Country
United States of America
Zip code
07080-2449
Phone
1-908-222-7000
Profile
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Company Overview
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
CEO: Dr. Stuart W. Peltz, PhD
Market: NASDAQ
Listing Date: 06/20/2013
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist